The award will fund Dr. Vyavahare’s study of a theranostic approach to treat abdominal aortic aneurysms (AAA). According to the National Heart, Lung and Blood Institute, most aortic aneurysms are AAA. Although small AAA rarely rupture, AAA can grow very large without causing symptoms.
A team of researchers at Clemson University is part of a new national institute aimed at advancing the United States’ leadership in the biopharmaceutical industry. Clemson bioengineering professor Dr. Sarah W. Harcum is the Clemson site director for this initiative.
The Clemson University Biomedical Engineering Innovation Center is a state-of-the art facility primarily dedicated to biomedical research and accelerated innovation. Read more
The Bioengineering Center of Regeneration and Formation of Tissues is the nation's only bioengineering COBRE center, researching methods to restore diseased tissues. Read more
The South Carolina Medical Translational Technology Program enables biomedical innovation through rapid translation of clinically driven technology and reinvestment of health care dollars into research. Read more